Expertise in
24
conditions

Dr. Stuart Gordon

Gastroenterology
Henry Ford Hospital
2799 W Grand Blvd, 
Detroit, MI 
Offers Telehealth
Expertise in
24
conditions
Henry Ford Hospital
2799 W Grand Blvd, 
Detroit, MI 

Overview

Stuart Gordon is a Gastroenterologist practicing medicine in Detroit, Michigan.

Dr. Gordon is highly rated in 24 conditions, according to our data. His clinical expertise encompasses Hepatitis, Hepatitis C, Primary Biliary Cholangitis, Endoscopy, and Liver Transplant.

He is actively involved in clinical research, co-authoring 228 peer reviewed articles and participating in 22 clinical trials.

Specialties

Gastroenterology

Licenses

Internal Medicine in MI

Hospital Affiliations

Henry Ford Health Hospital
Henry Ford Health West Bloomfield Hospital
Henry Ford Macomb Hospital
Wyandotte Hospital And Medical Center

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
CareSource
  • HMO
Cigna
  • EPO
  • HMO
  • PPO
Health Alliance Plan
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
McLaren Health
  • HMO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Meridian Choice
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Nippon Life
  • INSURANCE PLAN
Priority Health
  • HMO
  • POS
Spectrum Priority Health
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 14 Less Insurance Carriers -

Locations

Henry Ford Hospital
2799 W Grand Blvd, Detroit, MI 48202
Other Locations
Henry Ford Medical Center-Bloomfield Township
1961 S Telegraph Rd, Bloomfield Hills, MI 48302

Additional Areas of Focus

Dr. Gordon has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Non-Alcoholic Fatty Liver Disease
Nonalcoholic Steatohepatitis (NASH)

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

21 Clinical Trials

A Randomized, Open-Label, Multicenter Study Investigating AB-729, Nucleos(t)Ide Analogue and Pegylated Interferon Alfa-2a Treatment in Subjects With Chronic Hepatitis B Infection
A Randomized, Open-Label, Multicenter Study Investigating AB-729, Nucleos(t)Ide Analogue and Pegylated Interferon Alfa-2a Treatment in Subjects With Chronic Hepatitis B Infection
Enrollment Status: Completed
Publish Date: April 29, 2026
Intervention Type: Drug
Study Drugs: AB-729, Peg-IFN?-2a
Study Phase: Phase 2
A Randomized, Placebo-controlled Pilot Study of Sulfasalazine for the Treatment of Primary Sclerosing Cholangitis (PSC)
A Randomized, Placebo-controlled Pilot Study of Sulfasalazine for the Treatment of Primary Sclerosing Cholangitis (PSC)
Enrollment Status: Completed
Publish Date: March 12, 2026
Intervention Type: Drug
Study Drug: Sulfasalazine
Study Phase: Phase 2
A Phase 2a Double Blind, Placebo Controlled Study to Evaluate the Safety, Tolerability, Pharmacodynamics, and Efficacy of CNP-104 in Subjects Ages 18-75 With Primary Biliary Cholangitis Who Are Unresponsive to UDCA and/or OCA
A Phase 2a Double Blind, Placebo Controlled Study to Evaluate the Safety, Tolerability, Pharmacodynamics, and Efficacy of CNP-104 in Subjects Ages 18-75 With Primary Biliary Cholangitis Who Are Unresponsive to UDCA and/or OCA
Enrollment Status: Completed
Publish Date: March 10, 2026
Intervention Type: Drug
Study Drug: CNP-104
Study Phase: Phase 1/Phase 2
Long-term Safety and Tolerability Study of Linerixibat for the Treatment of Cholestatic Pruritus in Participants With Primary Biliary Cholangitis
Long-term Safety and Tolerability Study of Linerixibat for the Treatment of Cholestatic Pruritus in Participants With Primary Biliary Cholangitis
Enrollment Status: Active_not_recruiting
Publish Date: February 20, 2026
Intervention Type: Drug
Study Drug: Linerixibat
Study Phase: Phase 3
A Seamless, Adaptive, Phase 2b/3, Double-Blind, Randomized, Placebo-controlled, Multicenter, International Study Evaluating the Efficacy and Safety of Belapectin (GR MD-02) for the Prevention of Esophageal Varices in NASH Cirrhosis
A Seamless, Adaptive, Phase 2b/3, Double-Blind, Randomized, Placebo-controlled, Multicenter, International Study Evaluating the Efficacy and Safety of Belapectin (GR MD-02) for the Prevention of Esophageal Varices in NASH Cirrhosis
Enrollment Status: Terminated
Publish Date: February 20, 2026
Intervention Type: Drug
Study Drug: Belapectin
Study Phase: Phase 2/Phase 3
A Randomized Double-Blind Placebo-Controlled Study to Evaluate the Efficacy and Safety of Volixibat in the Treatment of Cholestatic Pruritus in Patients With Primary Sclerosing Cholangitis
A Randomized Double-Blind Placebo-Controlled Study to Evaluate the Efficacy and Safety of Volixibat in the Treatment of Cholestatic Pruritus in Patients With Primary Sclerosing Cholangitis
Enrollment Status: Active_not_recruiting
Publish Date: February 04, 2026
Intervention Type: Drug
Study Drug: Volixibat
Study Phase: Phase 2
A Two-part, Randomized, Placebo Controlled, Double Blind, Multicenter, Phase 3 Study to Evaluate the Efficacy and Safety of Linerixibat for the Treatment of Cholestatic Pruritus in Participants With Primary Biliary Cholangitis (PBC)
A Two-part, Randomized, Placebo Controlled, Double Blind, Multicenter, Phase 3 Study to Evaluate the Efficacy and Safety of Linerixibat for the Treatment of Cholestatic Pruritus in Participants With Primary Biliary Cholangitis (PBC)
Enrollment Status: Completed
Publish Date: July 22, 2025
Intervention Type: Drug
Study Drug: Linerixibat
Study Phase: Phase 3
A Phase 2, Randomized, Double Blind, Placebo Controlled, Multiple Center Study to Evaluate the Safety, Tolerability, and Efficacy of Seladelpar Administered for 24 Weeks in Adult Patients With Primary Sclerosing Cholangitis (PSC)
A Phase 2, Randomized, Double Blind, Placebo Controlled, Multiple Center Study to Evaluate the Safety, Tolerability, and Efficacy of Seladelpar Administered for 24 Weeks in Adult Patients With Primary Sclerosing Cholangitis (PSC)
Enrollment Status: Terminated
Publish Date: January 16, 2025
Intervention Type: Drug
Study Phase: Phase 2
A Phase 3, Double-Blind, Randomized, Long-Term, Placebo-Controlled, Multicenter Study Evaluating the Safety and Efficacy of Obeticholic Acid in Subjects With Nonalcoholic Steatohepatitis
A Phase 3, Double-Blind, Randomized, Long-Term, Placebo-Controlled, Multicenter Study Evaluating the Safety and Efficacy of Obeticholic Acid in Subjects With Nonalcoholic Steatohepatitis
Enrollment Status: Terminated
Publish Date: October 01, 2024
Intervention Type: Drug
Study Drug: Obeticholic Acid
Study Phase: Phase 3
A Prospective Single Arm Multicenter Study Evaluating the Effects of Spray Cryotherapy in Patients With Persistent Local Esophageal Cancer
A Prospective Single Arm Multicenter Study Evaluating the Effects of Spray Cryotherapy in Patients With Persistent Local Esophageal Cancer
Enrollment Status: Completed
Publish Date: May 08, 2024
Intervention Type: Device
Study Phase: Not Applicable
View 9 Less Clinical Trials

227 Total Publications

Glecaprevir/Pibrentasvir for Acute Hepatitis C Virus Infection in Individuals with a History of Prior Hepatitis C Infection.
Glecaprevir/Pibrentasvir for Acute Hepatitis C Virus Infection in Individuals with a History of Prior Hepatitis C Infection.
Journal: Infectious diseases and therapy
Published: March 16, 2026
Similar Doctors
Expertise in
20
conditions
Dr. Jessica Mellinger
Gastroenterology
Expertise in
20
conditions
Dr. Jessica Mellinger
Gastroenterology
Referral may be required

Henry Ford Hospital

2799 W Grand Blvd, 
Detroit, MI 
 (0.1 miles away)
313-916-2600
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Jessica Mellinger is a Gastroenterologist practicing medicine in Detroit, Michigan. Dr. Mellinger is highly rated in 20 conditions, according to our data. Her clinical expertise encompasses Alcoholic Cirrhosis, Cirrhosis, Hepatitis, Liver Transplant, and Endoscopy.

Expertise in
22
conditions
Dr. Dilip Moonka
Gastroenterology
Expertise in
22
conditions
Dr. Dilip Moonka
Gastroenterology
Referral may be required

Henry Ford Hospital

2799 W Grand Blvd, 
Detroit, MI 
 (0.1 miles away)
313-916-2600
Languages Spoken:
English
See accepted insurances

Dilip Moonka is a Gastroenterologist practicing medicine in Detroit, Michigan. Dr. Moonka is highly rated in 22 conditions, according to our data. His clinical expertise encompasses Hepatitis C, Hepatitis, Liver Cancer, Liver Transplant, and Kidney Transplant.

Expertise in
25
conditions
Dr. William D. Chey
Gastroenterology | Internal Medicine
Expertise in
25
conditions
Dr. William D. Chey
Gastroenterology | Internal Medicine
Referral may be required

Taubman Center

1500 E Medical Center Dr, Floor 3 Reception D, 
Ann Arbor, MI 
 (33.3 miles away)
888-229-7408
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Dr. Chey received his BA degree from the University of Pennsylvania and medical degree & training in internal medicine at the Emory University School of Medicine. He went on to complete a fellowship in gastroenterology at the University of Michigan. Since completing this fellowship, Dr. Chey has remained at the University of Michigan, where he is H. Marvin Pollard Professor of Gastroenterology, Professor of Nutrition Sciences, and Chief, Division of Gastroenterology & Hepatology. Dr. Chey runs a very active clinical research group which has received funding from federal and private sources. Dr. Chey has authored more than 400 manuscripts, reviews and book chapters yielding an H-index of 50. He is former Co-editor-in-Chief of the American Journal of Gastroenterology (2010-2016) and serves on the editorial boards of several other journals. He serves as a member of the Board of Trustees and in 2026, will become President of the American College of Gastroenterology. He is a member of the Board of Directors of the Rome Foundation and IFFGD. He has participated in and directed numerous national and international continuing medical education programs in gastroenterology, and has been elected to the roster of Best Doctors since 2001 and America's™ Top Doctors since 2009. Dr. Chey has received numerous awards including the Berk-Fise Award for outstanding clinical service from the ACG, the Distinguished Clinician Award from the AGA, Dean’s Outstanding Clinician Award, Dean’s Award for Innovation and Commercialization, and the Healio Disruptive Innovator Award. Dr. Chey is highly rated in 25 conditions, according to our data. His clinical expertise encompasses Irritable Bowel Syndrome (IBS), Diarrhea, Chronic Idiopathic Constipation (CIC), Endoscopy, and Colonoscopy. Dr. Chey is board certified in Internal Medicine and Gastroenterology.

Frequently Asked Questions about Dr. Stuart Gordon

How do I make an appointment with Dr. Stuart Gordon?

You can book an appointment with Dr. Stuart Gordon by calling their office at 313-916-2600. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Stuart Gordon a top-rated expert for Hepatitis?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Stuart Gordon is classified as an Elite expert for Hepatitis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Stuart Gordon specialize in?

While Dr. Stuart Gordon is a Gastroenterology, they have specific expertise in Hepatitis, Hepatitis C, and Primary Biliary Cholangitis. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Gastroenterology.

Does Dr. Stuart Gordon participate in research or clinical trials?

Yes. Dr. Stuart Gordon has published 227 articles and abstracts on conditions like Hepatitis. You can view a list of Dr. Stuart Gordon's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Stuart Gordon accept my insurance?

Dr. Stuart Gordon accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 313-916-2600 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Gordon's expertise for a condition
ConditionClose
View All 7 Elite Conditions
View All 12 Distinguished Conditions
View All 29 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile